Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
A global legal and regulatory guide to cryptocurrencies - Chapter 2
Global | Publication | June 2015
Norton Rose Fulbright’s global blockchain and cryptocurrency team has produced a global legal and regulatory guide to cryptocurrencies.
The guide is issued in a series of chapters, published monthly.
Chapter 2: Insuring cryptocurrency risks
As bitcoin and other virtual currencies become better established, so it is likely that demand for insurance to protect against the particular risks associated with them will increase. Even as matters stand, it would appear that a nascent bitcoin insurance market is beginning to emerge.
If cryptocurrencies do become more prevalent over time, the insurance industry will be looking carefully at the risks which it is able to insure and on what terms. In this chapter, we seek to identify and discuss some of the issues we believe may come into focus, as insurers start to undertake this exercise.
Other chapters in the series:
- Introduction to cryptocurrencies
- The legal nature of cryptocurrency
- Cryptocurrency litigation risks
- Taking security over cryptocurrency
- Regulation of cryptocurrencies
If you would like to discuss any aspect of this topic further, please get in touch.
Global head of FinTech
Email
sean.murphy@nortonrosefulbright.com
Recent publications
Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .